{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T23:23:36Z","timestamp":1751930616343},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We read with interest the publication on malaria treatment by Obonyo et al. (Malaria J 21:30, 2022). This commentary questions the methodology, especially the chosen time points of treatment outcome measures.<\/jats:p>","DOI":"10.1186\/s12936-022-04170-1","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T11:09:04Z","timestamp":1655723344000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Need for optimized dosages in the design of comparative clinical trials of anti-malarial drugs"],"prefix":"10.1186","volume":"21","author":[{"given":"Sanjeev","family":"Krishna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"key":"4170_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12936-022-04050-8","volume":"21","author":"CO Obonyo","year":"2022","unstructured":"Obonyo CO, Juma EA, Were VO, Ogutu BR. Efficacy of 3-day low dose quinine plus clindamycin versus artemether\u2013lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial. Malar J. 2022;21:30.","journal-title":"Malar J"},{"key":"4170_CR2","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1086\/430309","volume":"40","author":"M Ramharter","year":"2005","unstructured":"Ramharter M, Oyakhirome S, Klein Klouwenberg P, Ad\u00e9gnika AA, Agnandji ST, Missinou MA, et al. Artesunate\u2013clindamycin versus quinine\u2013clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis. 2005;40:1777\u201384.","journal-title":"Clin Infect Dis"},{"key":"4170_CR3","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/infdis\/158.6.1368","volume":"158","author":"PG Kremsner","year":"1988","unstructured":"Kremsner PG, Zotter GM, Feldmeier H, Graninger W, Rocha RM, Wiedermann G. A comparative trial of three regimens for treating uncomplicated falciparum malaria in Acre. Brazil J Infect Dis. 1988;158:1368\u201371.","journal-title":"Brazil J Infect Dis"},{"key":"4170_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/infdis\/169.2.467","volume":"169","author":"PG Kremsner","year":"1994","unstructured":"Kremsner PG, Winkler S, Brandts C, Neifer S, Bienzle U, Graninger W. Clindamycin in combination with chloroquine or quinine is an effective therapy for uncomplicated Plasmodium falciparum malaria in children from Gabon. J Infect Dis. 1994;169:467\u201370.","journal-title":"J Infect Dis"},{"key":"4170_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1128\/AAC.39.1.245","volume":"39","author":"W Metzger","year":"1995","unstructured":"Metzger W, Mordm\u00fcller B, Graninger W, Bienzle U, Kremsner PG. High efficacy of short-term quinine\u2013antibiotic combinations for treating adult malaria patients in an area in which malaria is hyperendemic. Antimicrob Agents Chemother. 1995;39:245\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"4170_CR6","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1128\/AAC.39.7.1603","volume":"39","author":"PG Kremsner","year":"1995","unstructured":"Kremsner PG, Radloff P, Metzger W, Wildling E, Mordm\u00fcller B, Philipps J, et al. Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob Agents Chemother. 1995;39:1603\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"4170_CR7","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1086\/513926","volume":"26","author":"B Mordm\u00fcller","year":"1998","unstructured":"Mordm\u00fcller B, Kremsner PG. Hyperparasitemia and blood exchange transfusion for treatment of children with falciparum malaria. Clin Infect Dis. 1998;26:850\u20132.","journal-title":"Clin Infect Dis"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04170-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-022-04170-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-022-04170-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T11:12:56Z","timestamp":1655723576000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-022-04170-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4170"],"URL":"https:\/\/doi.org\/10.1186\/s12936-022-04170-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"20 June 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"194"}}